Bristol Myers and 2seventy Bio slip following announcement of meeting with FDA to review Abecma sBLA Check out this morning's top movers from around Wall Street, compiled by The Fly.
HIGHER -
- Microsoft (MSFT) up 1% after announcing that Sam Altman and Greg Brockman, together with colleagues, will be joining Microsoft to lead a new advanced AI research team
- NRG Energy (NRG) up 1% after announcing departure of CEO Mauricio Gutierrez, and reaffirming both its full year 2023 and 2024 EBITDA outlook
UP AFTER EARNINGS -
- Legend Biotech (LEGN) up 4%
- Full Truck Alliance (YMM) up 4%
DOWN AFTER EARNINGS -
- Greenland Technologies (GTEC) down 13%
LOWER -
- Bristol Myers (BMY) and 2seventy Bio (TSVT) down 5% and 10%, respectively, after reporting the FDA Oncologic Drugs Advisory Committee will meet to review data supporting the supplemental Biologics License Application for Abecma for earlier lines of triple-class exposed relapsed or refractory multiple myeloma - RRMM - based on results from the pivotal Phase 3 KarMMa-3 study
- NanoString (NSTG) down 12% after the verdict of a jury in the U.S. District Court for the District of Delaware finding that NanoString GeoMx Digital Spatial Profiler products infringe patents licensed to 10x Genomics (TXG) and awarding approximately $31M in damages
Symbols:
MSFT NRG LEGN YMM GTEC BMY TSVT NSTG TXG Keywords: Fly Intel, Wall Street, Top Stories, Stocks